Pascal Soriot

Executive Director, Chief Executive Officer

Pascal Soriot

Chief Executive Officer

Pascal joined AstraZeneca as an Executive Director and Chief Executive Officer on 1 October 2012.

A French national, 53 year old Pascal joined AstraZeneca from Roche AG where he served as Chief Operating Officer of the company’s pharmaceuticals division since 2010.

Prior to that Pascal was Chief Executive Officer of Genentech, where he was credited with leading the successful merger between the San Francisco-based biologics business and Roche. Pascal joined the pharmaceutical industry in 1986 and has worked in senior management roles in the US, Asia and Europe.

Latest news

15 January 2013

AstraZeneca today unveiled changes to its executive leadership team. The new, expanded membership of AstraZeneca’s Senior Executive Team, which comes into effect immediately, includes increased representation of the company’s scientific expertise, key products and key markets.

Read the full press release